SMS Pharmaceuticals Balance Sheet
- Market cap
- ₹4,213 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹323.89 – ₹607.30
As of FY25, SMS Pharmaceuticals had total assets of ₹2,738 crore and borrowings of ₹506 crore, against shareholders' equity of ₹2,016 crore — a debt-to-equity ratio of 0.35.
SMS Pharmaceuticals balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 1,896 |
| Borrowings | 506 |
| Other liabilities | 337 |
| Total liabilities | 2,738 |
| Fixed assets | 1,475 |
| Capital work in progress | 45 |
| Investments | 632 |
| Other assets | 632 |
| Total assets | 2,738 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹157.84
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
SMS Pharmaceuticals balance sheet — frequently asked questions
What is the total debt of SMS Pharmaceuticals?
SMS Pharmaceuticals reported borrowings of ₹506 crore as of FY25.
What is SMS Pharmaceuticals' debt-to-equity ratio?
Based on the FY25 balance sheet, SMS Pharmaceuticals' debt-to-equity ratio is 0.35 — borrowings of ₹506 crore against equity capital and reserves of ₹2,016 crore.
What are SMS Pharmaceuticals' total assets?
SMS Pharmaceuticals' total assets were ₹2,738 crore as of FY25, including fixed assets of ₹1,475 crore and investments of ₹632 crore.
What is the book value per share of SMS Pharmaceuticals?
The book value per share of SMS Pharmaceuticals is ₹157.84, based on the latest reported balance sheet.
Same Data For Peers
Trade SMS Pharmaceuticals With ATS
Track SMSPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.